Workflow
*ST天山(300313) - 2024 Q1 - 季度财报
TIANSHAN BIOTIANSHAN BIO(SZ:300313)2024-04-23 10:12

Financial Performance - The company's revenue for Q1 2024 was ¥17,543,154.91, a decrease of 24.24% compared to ¥23,156,538.66 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥7,206,692.62, representing a decline of 79.45% from a loss of ¥4,015,972.23 in the previous year[5] - Total operating revenue for Q1 2024 was CNY 17,543,154.91, a decrease of 24.8% compared to CNY 23,156,538.66 in the same period last year[39] - Net loss for Q1 2024 was CNY 6,826,573.04, compared to a net loss of CNY 4,187,542.06 in Q1 2023, representing an increase in loss of 63.0%[40] - Total operating costs for Q1 2024 were CNY 24,744,512.43, down 10.1% from CNY 27,560,427.12 year-over-year[39] Cash Flow and Liquidity - The net cash flow from operating activities increased by 1.65% to ¥5,424,757.22, compared to ¥5,336,772.76 in the same period last year[5] - The cash inflow from operating activities increased by 42.61% to ¥30,809,346.05, while cash outflow increased by 56.05% to ¥25,384,588.83[11] - The company's cash flow from operating activities showed a significant decline, impacting liquidity and operational flexibility[41] - Cash received from sales of goods and services was $29,216,076.99, up from $20,969,025.16 in the previous period[42] - The ending balance of cash and cash equivalents was $22,446,910.25, down from $45,331,434.33 in the previous period[43] Assets and Liabilities - The total assets at the end of the reporting period were ¥313,554,522.36, a slight decrease of 0.53% from ¥315,229,860.70 at the end of the previous year[5] - Total liabilities increased to ¥248,142,997.32 from ¥243,236,762.62, an increase of 2.0%[38] - The company's total assets decreased to CNY 313,554,522.36 from CNY 315,229,860.70, a decline of 0.5%[38] - The company's equity attributable to shareholders decreased by 11.59% to ¥54,961,943.41 from ¥62,168,636.03 at the end of the previous year[5] - The total equity attributable to shareholders decreased to CNY 54,961,943.41 from CNY 62,168,636.03, a decline of 11.5%[38] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,169[13] - The top shareholder, Huzhou Haohui Enterprise Management Consulting Co., Ltd., holds 22.11% of the shares, amounting to 69,211,312 shares[13] - The controlling shareholder, Huzhou Haohui, signed a framework agreement to transfer control of 40,718,359 shares, representing 13.01% of the total shares, to China Electric Power Agricultural Innovation Technology Co., Ltd. (CEPA) [16] - As of the report date, Huzhou Haohui holds 69,211,312 shares, accounting for 22.11% of the total share capital, with 15,350,000 shares pledged, which is 22.18% of its holdings and 4.90% of the total share capital [20] - Chen Dehong holds 37,279,083 shares, representing 11.91% of the total share capital, with 36,509,768 shares pledged, which is 97.94% of his holdings and 11.67% of the total share capital [22] Legal Proceedings - The company is involved in ongoing legal proceedings related to the acquisition of Elephant Advertising, with significant shares expected to be returned following court rulings [19] - The company is involved in ongoing legal proceedings related to contract fraud, with significant financial implications from the case against Daxiang Advertising Co., Ltd. and its representatives[29] - The court has ruled to confiscate shares held by 30 defendants in the ongoing fraud case, with further actions pending regarding the return of these shares[30] - The company is actively pursuing the recovery of shares involved in legal disputes, with ongoing updates to be disclosed as the situation progresses[30] - The company has faced challenges related to stock pledges by former executives, with ongoing legal disputes regarding the validity of these pledges[33] Strategic Decisions and Future Plans - The company plans to liquidate and deregister its subsidiary Ningxia Meijia Agricultural Biotechnology Co., Ltd. due to unclear strategic direction and continuous losses, with net assets declining year by year[26] - A joint venture company named Guangdong Tiansheng Agricultural Technology Co., Ltd. was established with a registered capital of CNY 10 million, focusing on the beef supply chain in the Greater Bay Area and other regions[28] - The company aims to optimize resource allocation and reduce management costs through strategic decisions, including the liquidation of underperforming subsidiaries[26] - The company plans to enhance market expansion strategies and invest in new technologies to improve future performance[41] Investment and Income - The company reported a significant increase in investment income, rising by 115.40% to ¥1,140,575.71 from ¥529,509.64 in the previous year[10] - Cash inflow from investment activities totaled $1,454,790.00, compared to $148,172.00 in the previous period, marking a significant increase[43] - Net cash flow from investment activities improved to $1,344,790.00 from a negative $733,333.00 in the prior period[43] Research and Development - Research and development expenses rose to CNY 212,759.43 from CNY 181,359.78, an increase of 17.3% year-over-year, indicating a focus on innovation[40]